Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

To Purchase # 1037S

1037S 100 µg

To get local purchase information on this product, click here

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using Survivin (71G4) Rabbit mAb #2808 in the presence of control peptide (left) or Survivin Blocking Peptide (right).

Learn more about how we get our images
Image

Product Description

This peptide is used to specifically block Survivin (71G4) Rabbit mAb #2808 reactivity.


Quality Control

The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. The peptide blocks Survivin (71G4) Rabbit mAb #2808 by immunohistochemistry.

Product Usage Information

Use as a blocking reagent to evaluate the specificity of antibody reactivity in immunohistochemistry protocols. For immunohistochemistry, add twice the volume of peptide as volume of antibody used in 100 µl total volume. Incubate for a minimum of 30 minutes prior to adding the entire volume to the slide. Recommended antibody dilutions can be found on the relevant product data sheet.


Storage: Supplied in 20 mM potassium phosphate (pH 7.0), 50 mM NaCl, 0.1 mM EDTA, 1 mg/ml BSA and 5% glycerol. Store at –20°C.

Survivin is a 16 kDa anti-apoptotic protein highly expressed during fetal development and cancer cell malignancy (1). Survivin binds and inhibits caspase-3, controlling the checkpoint in the G2/M-phase of the cell cycle by inhibiting apoptosis and promoting cell division (2,3). This regulatory process requires the phosphorylation of survivin at Thr34 by p34 cdc2 kinase (4). Gene targeting using a Thr34 phosphorylation-defective survivin mutant, as well as antisense survivin, have been shown to inhibit tumor growth (5,6).


1.  Reed, J.C. and Reed, S.I. (1999) Nature Cell Biol. 1, 199-200.

2.  Li, F. et al. (1999) Nat. Cell Biol. 1, 461-466.

3.  O'Connor, D.S. et al. (2000) Proc. Natl. Acad. Sci. USA 97, 13103-13107.

4.  Li, F. et al. (1998) Nature 396, 580-584.

5.  Olie, R.A. et al. (2000) Cancer Res. 60, 2805-2809.

6.  Grossman, D. et al. (2001) Proc. Natl. Acad. Sci. USA 98, 635-640.


Entrez-Gene Id 332
Swiss-Prot Acc. O15392


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.